tiprankstipranks
Trending News
More News >
Veradigm (MDRX)
OTHER OTC:MDRX

Veradigm (MDRX) Price & Analysis

Compare
220 Followers

MDRX Stock Chart & Stats

$4.60
-$0.25(-2.56%)
At close: 4:00 PM EST
$4.60
-$0.25(-2.56%)

Veradigm News

MDRX FAQ

What was Veradigm’s price range in the past 12 months?
Veradigm lowest stock price was $3.00 and its highest was $9.25 in the past 12 months.
    What is Veradigm’s market cap?
    Veradigm’s market cap is $500.94M.
      When is Veradigm’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Veradigm’s earnings last quarter?
      Currently, no data Available
      Is Veradigm overvalued?
      According to Wall Street analysts Veradigm’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Veradigm pay dividends?
        Veradigm does not currently pay dividends.
        What is Veradigm’s EPS estimate?
        Veradigm’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Veradigm have?
        Veradigm has 108,900,000 shares outstanding.
          What happened to Veradigm’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Veradigm?
          Currently, no hedge funds are holding shares in MDRX
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            Veradigm

            Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising Practice Management software, AI Patient Scheduling Software, and Electronic Statements and Payments; revenue cycle management solutions, including Revenue Cycle Services and revenue cycle management clearinghouse; electronic health records solutions, which include ePrescribe with EPCS, EHR software, Veradigm HER, and Practice Fusion HER; and Patient Engagement Platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as Veradigm Connect, Veradigm App Expo, and Diagnostic Ordering and Resulting Network; Channel Partner Program; and Veradigm ePrescribe Enterprise. In addition, the company offers solutions to health plans and payers, comprising risk adjustment solutions, such as Health Equity Analytics, Risk Adjustment Analytics, Risk Mitigator, Comprehensive Submissions, and Utilization Analytics; quality management solutions, which include quality analytics and risk adjustment and quality management; data exchange+coding solutions, including eChart Courier, eChart Coder, and eChart Integration and Analytics; provider engagement and Veradigm Payer Insights; and Veradigm Payerpath solutions. Further, it provides solutions to biophama, including real world data solutions, such as real world and health data sets and cardiology and metabolic registries; real world evidence and Real World Evidence Analytics Platform; therapy focused solutions, such as cardiovascular, central nervous system, metabolic, and immunology data; and Digital Health Media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

            Veradigm (MDRX) Earnings & Revenues

            Similar Stocks
            Company
            Price & Change
            Follow
            HealthStream
            Spok Holdings
            National Research
            Clinigence Holdings
            Definitive Healthcare Corp

            Ownership Overview

            41.05%1.52%0.88%56.54%
            41.05% Insiders
            0.88% Other Institutional Investors
            56.54% Public Companies and
            Individual Investors

            Options Prices

            Currently, No data available
            ---
            Popular Stocks